EBS (STOCKS)
Emergent Biosolutions, Inc.
$4.491800
-0.058200 (-1.28%)
Prev close: $4.550000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Joseph C. Papa
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $230.22M
- Employees
- 900
- P/E (TTM)
- -1.28
- P/B (TTM)
- 0.68
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $770.20M |
| Benefits Costs and Expenses | $916.20M |
| Cost Of Revenue | $339.90M |
| Costs And Expenses | $916.20M |
| Gross Profit | $430.30M |
| Nonoperating Income/Loss | -$80.00M |
| Operating Expenses | $496.30M |
| Selling, General, and Administrative Expenses | $181.20M |
| Research and Development | $45.30M |
| Other Operating Expenses | $269.80M |
| Operating Income/Loss | -$66.00M |
| Income/Loss From Continuing Operations After Tax | -$176.80M |
| Income/Loss From Continuing Operations Before Tax | -$146.00M |
| Income Tax Expense/Benefit | $30.80M |
| Net Income/Loss | -$176.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$176.80M |
| Net Income/Loss Available To Common Stockholders, Basic | -$176.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.41 |
| Diluted Earnings Per Share | -$3.47 |
| Basic Average Shares | 156,300,000 |
| Diluted Average Shares | 164,600,000 |
| Assets | $1.12B |
| Current Assets | $666.00M |
| Inventory | $303.60M |
| Other Current Assets | $362.40M |
| Noncurrent Assets | $450.80M |
| Fixed Assets | $178.00M |
| Intangible Assets | $261.80M |
| Other Non-current Assets | $11.00M |
| Liabilities | $775.40M |
| Current Liabilities | $122.80M |
| Accounts Payable | $50.20M |
| Wages | $26.20M |
| Other Current Liabilities | $46.40M |
| Noncurrent Liabilities | $652.60M |
| Long-term Debt | $589.70M |
| Other Non-current Liabilities | $62.90M |
| Equity | $341.40M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $341.40M |
| Liabilities And Equity | $1.12B |
| Net Cash Flow From Operating Activities | $97.70M |
| Net Cash Flow From Operating Activities, Continuing | $97.70M |
| Net Cash Flow From Investing Activities | -$62.00M |
| Net Cash Flow From Investing Activities, Continuing | -$62.00M |
| Net Cash Flow From Financing Activities | -$165.60M |
| Net Cash Flow From Financing Activities, Continuing | -$165.60M |
| Exchange Gains/Losses | -$200.00K |
| Net Cash Flow | -$130.10M |
| Net Cash Flow, Continuing | -$129.90M |
| Comprehensive Income/Loss | -$176.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$175.50M |
| Other Comprehensive Income/Loss | -$182.90M |
| Other Comprehensive Income/Loss Attributable To Parent | $1.30M |